• Telehealth visits
bch logo

Tony T. Yang, MD, PhD

Psychiatry (Child and Adolescent Psychiatry)
Pediatric Psychiatry & Psychology Mission Bay
877-822-4453
bch logo

Tony T. Yang, MD, PhD

Psychiatry (Child and Adolescent Psychiatry)
Pediatric Psychiatry & Psychology Mission Bay
877-822-4453
  • Telehealth visits

On this page

About me

Dr. Tony T. Yang is a psychiatrist who specializes in diagnosing and treating depression in adolescents.

In his research, Yang studies depression in adolescents using functional MRI, which measures brain activity by detecting changes associated with blood flow. He has received funding support for his research from the Brain & Behavior Research Foundation, Klingenstein Third Generation Foundation and National Institute of Mental Health.

Yang earned a doctorate in molecular pathology at the University of California, San Diego, before earning his medical degree from the UC San Diego School of Medicine. He completed a residency in general psychiatry and a fellowship in child and adolescent psychiatry at Stanford University School of Medicine.

Education & training

Board certification

  • Child & Adolescent Psychiatry, American Board of Psychiatry and Neurology
  • Psychiatry, American Board of Psychiatry and Neurology

Fellowship

  • Child and Adolescent Psychiatry, Stanford University Psychiatry & Behavior Sci GME

Residency

  • Stanford University Psychiatry & Behavior Sci GME

Degree

  • MD, University of California San Diego School of Medicine

Academic Title

  • Professor-in-Residence

Locations

    Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

    For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.

    The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.